title: Early stage and long term treatment of multiple sclerosis with interferon-beta.
abstract: Multiple sclerosis (MS) affects young adults during the most productive years of their lives, and until recently many neurologists were limited to treating symptoms and attacks without any ability to alter the disease course. The 1990s ushered in an era of possibility with the approval of three interferon-beta (IFNbeta) therapies for the treatment of MS. Though the mechanism of action of these agents is not completely understood, it is clear they reduce magnetic resonance imaging (MRI) activity as well as improve clinical outcomes. The principal randomized, blinded, multicenter trials of IFNbeta all point to the need for early treatment soon after the diagnosis of MS is made. Efficacy has also been shown in patients treated after a first demyelinating event. Data on IFNbeta in the treatment of secondary progressive MS (SPMS) is not impressive, although it shows some benefit in SPMS patients who continue to experience MRI activity and clinical relapses, signifying a continued inflammatory component to their disease. There has been no proven efficacy of IFNbeta in the treatment of primary progressive MS (PPMS). The IFNbeta therapies are generally well tolerated with a favorable side effect profile. Despite benefits in MRI and clinical measures such as relapse rates and Expanded Disability Status Scale progression, patients continue to exhibit clinical progression and radiological atrophy, pointing to confounding factors and perhaps multiple etiologies of a disease that is not yet fully understood. In addition, the subject of neutralizing antibodies has recently assumed importance. The significance of these on treatment efficacy is uncertain, and until a universally accepted reliable assay is adopted, the decision to change treatment continues to rely on the clinical interpretation of the patient's history and physical examination. Additional recommendations for management of patients, informed by the best available evidence, are also presented.
authors.affiliation: Department of Neurology, University of Vermont College of Medicine, and Neurology Service, Fletcher Allen Health Care, Burlington, VT, USA.
authors.forename: Angela
authors.initials: A
authors.lastname: Applebee
authors.forename: Hillel
authors.initials: H
authors.lastname: Panitch
references.citation: Lancet. 1998 Nov 7;352(9139):1491-7
references.pmid: 9820296
references.citation: Ann Neurol. 1997 May;41(5):669-74
references.pmid: 9153530
references.citation: Neurology. 2002 Nov 12;59(9):1412-20
references.pmid: 12427893
references.citation: Neurology. 2001 May 22;56(10):1416
references.pmid: 11376205
references.citation: J Interferon Res. 1993 Oct;13(5):333-40
references.pmid: 8301153
references.citation: Neurology. 2007 Mar 27;68(13):977-84
references.pmid: 17389300
references.citation: Neurology. 2002 Sep 24;59(6):802-8
references.pmid: 12349849
references.citation: Mult Scler. 2007 May;13(4):459-70
references.pmid: 17463069
references.citation: Ann Neurol. 2001 May;49(5):677-81
references.pmid: 11357961
references.citation: Neurobiol Dis. 1999 Jun;6(3):149-66
references.pmid: 10408805
references.citation: Ann Neurol. 1983 Mar;13(3):227-31
references.pmid: 6847134
references.citation: Drug Saf. 2003;26(11):815-27
references.pmid: 12908850
references.citation: Neurology. 1996 Jan;46(1):12-8
references.pmid: 8559358
references.citation: Neurology. 1999 Apr 12;52(6):1277-9
references.pmid: 10214759
references.citation: Neurology. 2002 Apr 23;58(8 Suppl 4):S3-9
references.pmid: 11971121
references.citation: Nat Immunol. 2001 Sep;2(9):785-8
references.pmid: 11526386
references.citation: Neurology. 2002 Jan 22;58(2):169-78
references.pmid: 11805241
references.citation: Neurology. 2004 Feb 24;62(4):628-31
references.pmid: 14981183
references.citation: Neurology. 2006 Apr 11;66(7):1056-60
references.pmid: 16510769
references.citation: Lancet. 2001 May 19;357(9268):1576-82
references.pmid: 11377645
references.citation: Lancet. 2004 Oct 23-29;364(9444):1489-96
references.pmid: 15500893
references.citation: Neurology. 2006 Oct 10;67(7):1242-9
references.pmid: 16914693
references.citation: J Neuroimmunol. 2005 Apr;161(1-2):169-76
references.pmid: 15748956
references.citation: Neurology. 1999 Nov 10;53(8):1622-7
references.pmid: 10563602
references.citation: Neurology. 2004 Nov 23;63(10):1788-95
references.pmid: 15557491
references.citation: Neurology. 1996 Apr;46(4):907-11
references.pmid: 8780061
references.citation: Mult Scler. 2009 Feb;15(2):219-28
references.pmid: 18755819
references.citation: Neurology. 2002 Nov 26;59(10):1507-17
references.pmid: 12451189
references.citation: Mult Scler. 2007 Nov;13(9):1138-45
references.pmid: 17967841
references.citation: J Interferon Cytokine Res. 2008 May;28(5):317-31
references.pmid: 18547162
references.citation: Neurology. 2001 Jun 12;56(11):1496-504
references.pmid: 11402106
references.citation: Neurology. 2001 Jun 26;56(12):1628-36
references.pmid: 11425926
references.citation: Neurology. 1983 Nov;33(11):1444-52
references.pmid: 6685237
references.citation: Mult Scler. 1999 Aug;5(4):244-50
references.pmid: 10467383
references.citation: J Neuroimmunol. 2008 Mar;195(1-2):116-20
references.pmid: 18279974
references.citation: Ann Neurol. 2001 Jul;50(1):121-7
references.pmid: 11456302
references.citation: Ann Neurol. 1996 Dec;40(6):853-63
references.pmid: 9007090
references.citation: J Neuroimmunol. 2001 Nov 1;120(1-2):199-207
references.pmid: 11694335
references.citation: Clin Ther. 1997 Sep-Oct;19(5):883-93
references.pmid: 9385477
references.citation: Neurology. 2002 Sep 10;59(5):679-87
references.pmid: 12221157
references.citation: Neurology. 1999 Jun 10;52(9):1893-5
references.pmid: 10371541
references.citation: Neurology. 2002 Nov 26;59(10):1496-506
references.pmid: 12451188
references.citation: Mult Scler. 2007 Nov;13(9):1153-60
references.pmid: 17967843
references.citation: Neurology. 2005 Sep 27;65(6):807-11
references.pmid: 16186517
references.citation: Ann Neurol. 1999 Aug;46(2):197-206
references.pmid: 10443885
references.citation: Brain. 2003 Jun;126(Pt 6):1419-29
references.pmid: 12764062
references.citation: Arch Neurol. 2001 Aug;58(8):1297-8
references.pmid: 11493173
references.citation: Mult Scler. 1996 Apr;1(5):262-9
references.pmid: 9345428
references.citation: Lancet. 2007 Aug 4;370(9585):389-97
references.pmid: 17679016
references.citation: Neurology. 1995 Jul;45(7):1277-85
references.pmid: 7617182
references.citation: Neurology. 1998 Dec;51(6):1698-702
references.pmid: 9855525
references.citation: Neurology. 2001 Jun 12;56(11):1505-13
references.pmid: 11402107
references.citation: Arch Neurol. 2005 May;62(5):785-92
references.pmid: 15883267
references.citation: Ann Neurol. 1996 Mar;39(3):285-94
references.pmid: 8602746
references.citation: J Neurol. 2004 Mar;251(3):305-9
references.pmid: 15015010
references.citation: J Neuroimmunol. 2007 Apr;185(1-2):168-74
references.pmid: 17328965
references.citation: Neurology. 1999 Sep 11;53(4):679-86
references.pmid: 10489026
references.citation: Mult Scler. 2004 Apr;10(2):139-44
references.pmid: 15124757
references.citation: Neurology. 1993 Apr;43(4):662-7
references.pmid: 8469319
references.citation: Neurology. 1998 Sep;51(3):682-9
references.pmid: 9748010
references.citation: Arch Neurol. 2005 Apr;62(4):563-8
references.pmid: 15824253
references.citation: Ann Neurol. 2004 Aug;56(2):192-205
references.pmid: 15293271
references.citation: J Neurol Sci. 2005 Dec 15;239(1):67-74
references.pmid: 16169561
references.citation: Ann Neurol. 2000 Dec;48(6):885-92
references.pmid: 11117545
references.citation: Neurology. 2006 Sep 26;67(6):944-53
references.pmid: 17000959
references.citation: Lancet. 2002 Apr 27;359(9316):1453-60
references.pmid: 11988242
references.citation: J Neuroimmunol. 1993 Jul;46(1-2):145-53
references.pmid: 8360326
references.citation: Brain. 2008 Mar;131(Pt 3):808-17
references.pmid: 18234696
references.citation: J Neurol Sci. 2007 Jan 31;252(2):121-9
references.pmid: 17188301
references.citation: Lancet. 1998 Nov 7;352(9139):1498-504
references.pmid: 9820297
references.citation: Neurology. 2004 Nov 23;63(10):1779-87
references.pmid: 15557490
references.citation: Neurology. 2003 Jan 14;60(1):44-51
references.pmid: 12525716
references.citation: N Engl J Med. 2000 Sep 28;343(13):898-904
references.pmid: 11006365
references.citation: Ann Neurol. 1995 May;37(5):611-9
references.pmid: 7755356
references.citation: J Neuroimmunol. 1999 Dec;100(1-2):252-9
references.pmid: 10695735
references.citation: Neurology. 1997 Aug;49(2):358-63
references.pmid: 9270562
references.citation: Ann Neurol. 1996 Dec;40(6):846-52
references.pmid: 9007089